Titan Medical Inc.
Titan Medical Inc. (TMDIF) Stock Overview
Explore Titan Medical Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.9M
P/E Ratio
-17.93
EPS (TTM)
$-1.25
ROE
-1.38%
TMDIF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Titan Medical Inc. (TMDIF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1.25.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.93 and a market capitalization of 13.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
Thomas Looby
4
76 Berkeley Street, Toronto, ON
2010